Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ARCC4 |
Trade Name | |
Synonyms | ARCC-4|ARCC 4 |
Drug Descriptions |
ARCC4 is a proteolysis targeting chimera (PROTAC) targeting the androgen receptor (AR), which potentially induces AR degradation and inhibits tumor cell growth (PMID: 30271980). |
DrugClasses | Hormone - Anti-androgens 54 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ARCC4 | ARCC4 | 0 | 0 |
ARCC4 + Dabrafenib | ARCC4 Dabrafenib | 1 | 0 |